Antimicrobial agents and Burkholderia pseudomallei: perspectives from Thailand

Panomket, Pawana

doi:10.5372/1905-7415.0802.276

References

1. Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989; 159:890-99.10.1093/infdis/159.5.890
Open DOI Search in Google Scholar Back to article
2. Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis. 1989; 11:413-25.10.1093/clinids/11.3.413
Open DOI Search in Google Scholar Back to article
3. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005; 18:383-416.10.1128/CMR.18.2.383-416.2005
Open DOI Search in Google Scholar Back to article
4. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124:783-801.10.1016/j.cell.2006.02.015
Open DOI Search in Google Scholar Back to article
5. Wiersinga WJ, van der Poll T. Immunity to Burkholderia pseudomallei. Curr Opin Infect Dis. 2009; 22:102-8.10.1097/QCO.0b013e328322e727
Open DOI Search in Google Scholar Back to article
6. Wiersinga W, Wieland C, Dessing M, Chantratita N, Cheng AC. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med. 2007; 4:e248.10.1371/journal.pmed.0040248
Open DOI Search in Google Scholar Back to article
7. Panomket P, Splitter G, Harms J, Sermswan RW, Chedchotisakd P, Wongratanacheewin S. TBK1 does not play a role in the control of in vitro Burkholderia pseudomallei growth. Trans R Soc Trop Med Hyg. 2008; 102 (suppl 1):S95-100.10.1016/S0035-9203(08)70023-3
Open DOI Search in Google Scholar Back to article
8. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun. 1999; 67: 3593-600.10.1128/IAI.67.7.3593-3600.199911654910377144
Search in Google Scholar Back to article
9. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptor and immune recognition. Ann Rev Immunol. 2005; 23: 901-44.10.1146/annurev.immunol.23.021704.11581615771589
Open DOI Search in Google Scholar Back to article
10. Martineau AR, Newton SM, Wilkinson KA, Kampmann B, Hall BM, Nawroly N, et al. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. PloS Negl Trop Dis. 2009; 3:e407.10.1371/journal.pntd.0000407266060919352426
Open DOI Search in Google Scholar Back to article
11. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. The neutrophil as a cellular source of chemokines. Immunol Rev. 2000; 177: 195-203.10.1034/j.1600-065X.2000.17706.x
Open DOI Search in Google Scholar Back to article
12. Segal AW. How neutrophils kill microbes. Ann Rev Immunol. 2004; 23:197-223.10.1146/annurev.immunol.23.021704.115653
Open DOI Search in Google Scholar Back to article
13. Tippayawat P, Saenwongsa W, Mahawantung J, Suwannasaen D, Chetchotisakd P, Limmathurotsakul D, et al. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. PLoS Negl Trop Dis. 2009; 3:e407.10.1371/journal.pntd.0000407
Open DOI Search in Google Scholar Back to article
14. Vasu C, Vadivelu J, Puthucheary SD. The humoral immune response in melioidosis patients during therapy. Infection. 2003; 31:24-30.10.1007/s15010-002-3020-2
Open DOI Search in Google Scholar Back to article
15. White NJ. Melioidosis. Lancet. 2003; 361:1715-22.10.1016/S0140-6736(03)13374-0
Open DOI Search in Google Scholar Back to article
16. Chaowagul W. Recent advances in the treatment of severe melioidosis. Acta Tropica. 2000; 74:133-37.10.1016/S0001-706X(99)00062-5
Open DOI Search in Google Scholar Back to article
17. Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson Andrew JH, et al. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprimsulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis. 2005; 41:1105-13.10.1086/444456
Open DOI Search in Google Scholar Back to article
18. Jenny AWJ, Lum G, Fisher DA, Currie BJ. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents. 2001; 17: 109-13.10.1016/S0924-8579(00)00334-4
Open DOI Search in Google Scholar Back to article
19. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. Antibiotics susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. JAC. 2004; 54: 1134-8.10.1093/jac/dkh47115509614
Search in Google Scholar Back to article
20. Wuthiekanun V, Amornchai P, Saiprom N, Chantratita N, Chierakul W, Koh GCKW, et al. Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in northeast Thailand. Antimicrob Agents Chemother. 2011; 11: 5388-91.10.1128/AAC.05517-11319505421876049
Search in Google Scholar Back to article
21. Dance DA. Melioidosis. Curr Opin Infect Dis. 2002; 15:127-32.10.1097/00001432-200204000-00005
Open DOI Search in Google Scholar Back to article
22. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet. 1989; 2: 697-701.10.1016/S0140-6736(89)90768-X
Open DOI Search in Google Scholar Back to article
23. Vorachit M, Lam K, Jayanetra P, Costerton JW. Electron microscopy study of the mode of growth of Pseudomonas pseudomallei in vitro and in vivo. J Trop Med Hyg. 1995; 98:379-91.
Search in Google Scholar Back to article
24. Taweechaisupapong S, Kaewpa C, Arunyanart C, Kanla P, Homchumpa P. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Microb Pathog. 2005; 39:77-85.10.1016/j.micpath.2005.06.00116084684
Open DOI Search in Google Scholar Back to article
25. Vorachit M, Lam K, Jayanetra P, Costerton JW. Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic disc to ceftazidime and cotrimoxazole. Antimicrob Agents Chemother. 1993; 37: 2000-2.10.1128/AAC.37.9.20001881097694545
Search in Google Scholar Back to article
26. Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One. 2010; 5:e9196.10.1371/journal.pone.0009196282054620169199
Search in Google Scholar Back to article
27. Lee HS, Gu F, Ching SM, Lam Y, Chua KL. CdpA, a Burkholderia pseudomallei cyclic-di-GMP phosphodiesterase involved in autoaggregation, flagella synthesis, motility, biofilm formation, cell invasion and cytotoxicity. Infect immune. 2010; 78: 1832-40.10.1128/IAI.00446-09286350520194589
Search in Google Scholar Back to article
28. Korbsrisate S, Vanaporn M, Kerdsuk P, Kespichayawattana W, Vattanaviboon P, Kiatpapan P, et al. The Burkholderia pseudomallei RpoE (AIgU) operon is involved in environmental stress tolerance and biofilm formation. FEMS Microbial Lett. 2005; 252:243-9.10.1016/j.femsle.2005.09.00216185818
Search in Google Scholar Back to article
29. Puknum A, Tungpradabkul S, Taweechaisupapong S. Proteomic study of Burkholderia pseudomallei wild type and biofilm defective mutant in biofilm stimulating condition. Poster presentation on Commission on Higher Education Congress III University Staff Development. 2010.
Search in Google Scholar Back to article
30. Niumsup P, Wuthiekanun V. Cloning of the class D - lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime susceptible and resistant strains. JAC. 2002; 50:445-55.10.1093/jac/dkf16512356787
Search in Google Scholar Back to article
31. Livermore DM, Chau PY, Wong, AI, Leung YK. β-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance. J Antimicrob Chemother. 1987; 20:313-21.10.1093/jac/20.3.3133500161
Open DOI Search in Google Scholar Back to article
32. Cheung TK, Ho PL, Woo PC, Yuen KY, Chau PY. Cloning and expression of class A β-lactamase gene blaABPS in Burkholderia pseudomallei. Antimicrob Agents Chemother. 2002; 46:1132-5.10.1128/AAC.46.4.1132-1135.200212709111897607
Search in Google Scholar Back to article
33. Chantratita N, Rholl DA, Sim B, Wuthiekanum V, Limmathurotsakul D, Amornchai P, et al. Antimicrobial resistance to ceftazidime involving loss of penicillinbinding protein 3 in Burkholderia pseudomallei. PNAS. 2012; 108:17165-70.10.1073/pnas.1111020108
Search in Google Scholar Back to article
34. Davidson RN, Griffiths CJ, Wilkinson RJ. Neutrophil mediated innate immune resistance to mycobacteria. J Clin Invest. 2007; 117:1988-94.10.1172/JCI31097
Open DOI Search in Google Scholar Back to article
35. Kanthawong S, Nazmi K, Wongratanacheewin S, Bolscher JGM, Wuthiekanun V, Taweechaisupapong S. In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides. Int J Antimicrob Agents. 2009; 34:309-14.10.1016/j.ijantimicag.2009.05.012
Open DOI Search in Google Scholar Back to article
36. Panomket P, Wanrum S, Srivoramas T, Prongprom N. Bioactivity of plant extracts against Burkholderia pseudomallei. Asian Biomed. 2012; 6:619-23.
Search in Google Scholar Back to article
37. Cheng AC, Stephens DP, Anstey NM, Currie BJ. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis. 2004; 38:32-7.10.1086/380456
Open DOI Search in Google Scholar Back to article
38. Powell K, Ulett G, Hirst R, Norton R. G-CSF immunotherapy for treatment of acute disseminated murine melioidosis. FEMS Microbiol Lett. 2003; 224:315-8.10.1016/S0378-1097(03)00473-7
Open DOI Search in Google Scholar Back to article
39. Cheng AC, Limmathurotsakul D, Chierakul W, Getchalarat N, Wuthiekanun V, Stephens DP, et al. A randomized controlled trial of granulocyte colonystimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis. 2007; 45:308-14.10.1086/51926117599307
Open DOI Search in Google Scholar Back to article
40. Panomket P, Chetchotisakd P, Sermswan RW, Pannengpetch P, Wongratanacheewin S. Use of low dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei. Ann Trop Med Parasitol. 2009; 103: 635-46. 10.1179/000349809X1250203577611719825285
Open DOI Search in Google Scholar Back to article

Antimicrobial agents and Burkholderia pseudomallei: perspectives from Thailand

References

Paradigm

My account